Key facts
- This page summarizes William H. Adkins's Form 4 filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jan 2023, 15:10.
William H. Adkins - 29 Dec 2022 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- Reporting relationship
- Former Director
- Issuer ticker
- SHPH
- Reported as of
- 29 Dec 2022
- Net transaction value
- -$1,597
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2023, 15:10:42 UTC
- Prior SEC filing
- 07 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ William H. Adkins
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
William H. Adkins filed Form 4 for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on 04 Jan 2023.
Change
- Previous filing in this sequence was filed on 07 Sep 2022.
- Current net transaction value: -$1,597.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHPH
transaction
COMMON STOCK
Sale
- Transaction value
- $1,597
- Shares
- -995
- Change %
- -0.54%
- Price
- $1.60
- Shares after
- 184,071
- Date
- 29 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SHPH
transaction
Derivative
WARRANTS (right to buy)
Other
- Transaction value
- Shares
- +138,889
- Change %
- Price
- Shares after
- 138,889
- Date
- 02 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 138,889
- Exercise price
- $4.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
William H. Adkins is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
Footnote F2
Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust").
Footnote F3
Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.
SEC remarks
Previously, the Reporting Person's warrant holdings had been reported in Table I of the Reporting Person's Form 3. This Form 4 has corrected the error and moved the warrant holdings to Table II. The Reporting Person ceased being a director of SHPH in December 2022 and is no longer subject to Section 16 reporting requirements.